Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma

ConclusionWe found that the downregulation of DDX60L expression correlated with poor prognosis in patients with HCC, which may be independent of the HCV-related pathway. Furthermore, DDX60L significantly inhibited the proliferation of Hep3B cells, migration and invasion of Hep3B and HCCLM3 cells. Therefore, DDX60L can serve as a prognostic biomarker and therapeutic target for HCC.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research